Compare WSFS & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WSFS | HAE |
|---|---|---|
| Founded | 1980 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.8B |
| IPO Year | 1995 | 1996 |
| Metric | WSFS | HAE |
|---|---|---|
| Price | $78.60 | $105.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $76.20 | ★ $84.13 |
| AVG Volume (30 Days) | 303.6K | ★ 851.1K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | ★ 15.42 | N/A |
| EPS | ★ 3.26 | 0.72 |
| Revenue | ★ $963,949,000.00 | $910,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.40 | $5.23 |
| P/E Ratio | ★ $24.12 | $148.06 |
| Revenue Growth | ★ 50.18 | N/A |
| 52 Week Low | $49.92 | $47.32 |
| 52 Week High | $82.94 | $109.57 |
| Indicator | WSFS | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 76.00 |
| Support Level | $77.08 | $79.52 |
| Resistance Level | $79.13 | N/A |
| Average True Range (ATR) | 1.14 | 2.69 |
| MACD | -0.49 | 0.88 |
| Stochastic Oscillator | 26.45 | 85.29 |
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: the WSFS Bank segment provides loans and leases, and other financial products to commercial and consumer customers; the Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and the Wealth and Trust segment provides a broad array of planning and advisory services, investment management, trust services, and credit and deposit products to individual, corporate, and institutional clients. The majority of revenue is generated from the WSFS Bank segment.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.